Senti Biosciences Holdings SNTI
NASDAQ SNTI
$0.16 +0.02 (+11.81%)
At close: Nov 11, 2026 · 4:00 PM EST

Senti Biosciences Holdings (SNTI) Asset Writedowns and Impairment (2021 - 2025)

Updated

Senti Biosciences Holdings (SNTI) reported Asset Writedowns and Impairment of $5.1 million for Q4 2025, compared with $300,000 a year earlier.

Analysis

Senti Biosciences Holdings (SNTI) Asset Writedowns and Impairment (2021 - 2025) Analysis & Trends

Dating back to Q3 2023, Senti Biosciences Holdings' Asset Writedowns and Impairment record includes 4 quarters.

  • By year, Asset Writedowns and Impairment came in at $313,000 in FY2024 (-98.8%) and $25.96 million in FY2023.
  • The Q4 2025 figure ranks as the highest quarterly Asset Writedowns and Impairment since Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Senti Biosciences Holdings 4.36 Mn -39.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 5.10 Mn
Dec 31, 2024 300,000.00
Dec 31, 2023 262,000.00
Sep 30, 2023 25.69 Mn
Jun 30, 2022 1,000.00
Mar 31, 2022 12,000.00
Dec 31, 2021 13,000.00
Sep 30, 2021 9,000.00
API Access

Senti Biosciences Holdings Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=SNTI&period=max&api_key=YOUR_API_KEY